News Releases
Nov 17 2006
Peregrine Initiates Patient Treatment in Bavituximab Combination Therapy Cancer Trial
Nov 2 2006
Peregrine Pharmaceuticals to Present at Rodman & Renshaw 8th Annual Healthcare Conference
Oct 30 2006
Positive Results From Peregrine's Bavituximab Phase Ia HCV Trial Presented At AASLD Meeting
Oct 25 2006
Peregrine Pharmaceuticals to Present at C.E. Unterberg, Towbin Life Sciences Conference
Oct 24 2006
Peregrine Completes Patient Enrollment in Phase Ib Bavituximab Hepatitis C Trial
Oct 23 2006
Peregrine Pharmaceuticals Announces Annual Meeting Webcast
Oct 13 2006
Peregrine Pharmaceuticals to Present at BIO InvestorForum
Oct 12 2006
Peregrine Receives Regulatory Approval for New Cotara(R) Brain Cancer Clinical Trial
Sep 26 2006
Peregrine Announces Issuance of Broad Patent Covering Vascular Targeting Agents in Combination Therapy Regimens
Sep 19 2006
Researchers Report Peregrine's Phospholipid-Targeted Antibodies Fused With Cytokines Reduce Tumor Growth in Animals by Over 90%